The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-021-22101-7
Affiliations:
26
Authors:
32
Institutions Authors Share
The University of Western Australia (UWA), Australia
8.916667
0.28
Harry Perkins Institute of Medical Research (HPIMR), Australia
5.500000
0.17
Medical University of Gdańsk (MUG), Poland
3.833333
0.12
University of California, San Diego (UC San Diego), United States of America (USA)
2.000000
0.06
Monash University, Australia
1.000000
0.03
The University of Texas at Austin (UT Austin), United States of America (USA)
1.000000
0.03
State University of New York at Albany (SUNY Albany), United States of America (USA)
1.000000
0.03
Stanford Medicine, United States of America (USA)
1.000000
0.03
Fiona Stanley Hospital (FSH), Australia
1.000000
0.03
Institute of Bioorganic Chemistry, PAS, Poland
1.000000
0.03
University Clinical Centre in Gdańsk (UCK), Poland
1.000000
0.03
ARC Centre for Personalised Therapeutics Technologies (ARC CPTT), Australia
0.916667
0.03
Bellvitge Biomedical Research Institute (IDIBELL), Spain
0.833333
0.03
Biomedical Research Institute of Girona (IDIBGI), Spain
0.833333
0.03
Dessau Medical Center, Germany
0.500000
0.02
Edith Cowan University (ECU), Australia
0.500000
0.02
University of Otago, New Zealand
0.333333
0.01
Minia University, Egypt
0.333333
0.01
Dimerix Limited, Australia
0.250000
0.01
The University of Texas Health Science Center at San Antonio (UT Health San Antonio), United States of America (USA)
0.250000
0.01